Skip to main content
Fig. 6 | BMC Musculoskeletal Disorders

Fig. 6

From: Inhibition of SMAD3 effectively reduces ADAMTS-5 expression in the early stages of osteoarthritis

Fig. 6

ADAMTS-5 expression in OA cartilage tissue after intra-articular injection of SIS3 and miRNA-140 mimics. A, B ADAMTS-5 expression at 2 weeks. C, D ADAMTS-5 expression at 6 weeks. E, F ADAMTS-5 expression at 12 weeks. G, H ADAMTS-5 expression at 2 weeks. (I, J) ADAMTS-5 expression at 6 weeks. (K, L) ADAMTS-5 expression at 12 weeks. *, Compared to the blank group, P < 0.05. **, Compared to the blank group, P < 0.01.All the gels were trimmed and the samples derive from the same experiment and that gels/blots were processed in parallel

Back to article page